Engineers Gate Manager LP Seer, Inc. Transaction History

Engineers Gate Manager LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.24 $15,236 - $20,684	-9,234 Reduced 24.83%	27,951 $46,000
Q1 2024 May 15, 2024	BUY	$1.54 - $2.09 $11,585 - $15,723	7,523 Added 25.36%	37,185 $70,000
Q4 2023 Feb 14, 2024	SELL	$1.47 - $2.22 $14,967 - $22,604	-10,182 Reduced 25.55%	29,662 $57,000
Q3 2023 Nov 14, 2023	SELL	$2.18 - $5.52 $47,445 - $120,137	-21,764 Reduced 35.33%	39,844 $88,000
Q2 2023 Aug 14, 2023	BUY	$3.16 - $4.96 $141,359 - $221,880	44,734 Added 265.11%	61,608 $263,000
Q1 2023 May 15, 2023	BUY	$3.6 - $5.88 $60,746 - $99,219	16,874 New	16,874 $65,000
Q1 2022 May 16, 2022	SELL	$11.88 - $23.4 $146,040 - $287,656	-12,293 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$21.08 - $38.51 $259,136 - $473,403	12,293 New	12,293 $280,000
Q3 2021 Nov 15, 2021	SELL	$27.67 - $45.04 $191,033 - $310,956	-6,904 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$28.75 - $56.92 $198,490 - $392,975	6,904 New	6,904 $226,000

35.2M

600

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $135M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.